Plain-English translation of NCT05264025 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
Researchers are testing —a medication commonly used to treat allergies—as an add-on to your current rheumatoid arthritis medications. The goal is to see if this medication can help reduce joint inflammation and pain by working in a new way. This is an early-stage study with about 80 participants.
Current arthritis treatments don't work well enough for everyone, and some people can't take the strongest medications available. Researchers noticed that this medication might have anti-inflammatory properties that could help arthritis patients, so they want to test whether it could be a new treatment option.
You likely qualify if…
You likely don't qualify if…
You would take either the study medication or a placebo pill in addition to your regular arthritis medications. Half of the participants will receive the medication and half will receive placebo (neither you nor the researchers will know which at first). You would attend clinic visits for check-ups and blood work to see how the treatment affects your arthritis and overall health.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Egypt